Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis

We conducted a randomized, double-blind trial to assess the effect of 28.2 μg teriparatide versus placebo (1.4 μg teriparatide) on reduction of the incidence of vertebral fractures. Individuals enrolled in this study included patients with primary osteoporosis with one to five vertebral fractures an...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Takuo, Fukunaga, Masao, Itabashi, Akira, Tsutani, Kiichiro, Nakamura, Toshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899450/
https://www.ncbi.nlm.nih.gov/pubmed/23963633
http://dx.doi.org/10.1007/s00223-013-9777-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899450/
https://www.ncbi.nlm.nih.gov/pubmed/23963633
http://dx.doi.org/10.1007/s00223-013-9777-8

Ejemplares similares